Jeffrey Sugarman
Dermatology · Santa Rosa, CANPI 1548255482
Payments from drug & device makers
Across 910 payments — averaging $650.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$180K
- Sanofi$89K
- Pfizer$66K
- Incyte Corporation$57K
- Ultragenyx Pharmaceutical Inc.$48K
- AbbVie$36K
- plus $116K from 28 others
Across 207 payments — averaging $3147.27 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Bausch Health US, LLC$608K
- LEO Pharma AS$31K
- Pfizer$10K
- Mayne Pharma Commercial LLC$3K
What the payments were for
- Consulting fees$130,65126%
- Speaking & faculty fees$299,54161%
- Travel & lodging$42,7099%
- Food & beverage$21,1244%
- Education$2190%
- Gifts$80%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 212 | $179,607 |
| Sanofi | 85 | $89,245 |
| Pfizer | 61 | $65,923 |
| Incyte Corporation | 83 | $57,189 |
| Ultragenyx Pharmaceutical Inc. | 6 | $47,648 |
| AbbVie(2 entities) | 174 | $35,721 |
| Regeneron | 28 | $27,566 |
| Evolved By Nature, Inc. | 6 | $24,000 |
| Bausch Health US, LLC | 4 | $21,695 |
| E.r. Squibb & Sons, L.L.C. | 28 | $8,836 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 18 | $8,538 |
| Arcutis Biotherapeutics, Inc. | 20 | $7,310 |
| Novartis | 51 | $5,516 |
| Organon | 5 | $2,856 |
| Boehringer Ingelheim | 3 | $2,374 |
| LNHC, Inc | 4 | $2,349 |
| Dermavant Sciences, Inc. | 5 | $1,096 |
| Galderma Laboratories, L.p. | 9 | $962 |
| Johnson & Johnson | 27 | $766 |
| Lilly USA, LLC | 29 | $732 |
| Amgen | 13 | $451 |
| Nobelpharma America, LLC | 1 | $400 |
| Sun Pharmaceutical Industries Inc. | 6 | $245 |
| UCB, Inc. | 12 | $235 |
| LEO Pharma Inc. | 7 | $135 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $124 |
| Chiesi USA, Inc. | 2 | $73 |
| Almirall LLC | 1 | $49 |
| Akcea Therapeutics, Inc. | 2 | $47 |
| Genentech USA, Inc. | 2 | $43 |
| Biofrontera Inc. | 2 | $32 |
| Kyowa Kirin, Inc. | 1 | $23 |
| Fresenius Kabi USA, LLC | 1 | $23 |
| Medtronic | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$591,826 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 11 | $39,660 |
| Fluocinonide | 12 | $452 |
| Clobetasol Propionate | 15 | $404 |
| Hydrocortisone | 15 | $99 |
| Triamcinolone Acetonide | 19 | $74 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Santa Rosa
- Vivian LaquerIrvine$20.9M
- Howard SofenLos Angeles$16.1M
- Raja SivamaniSacramento$11.8M
- Jennifer SoungSanta Ana$10.3M
- Stacy SmithEncinitas$7.9M
- Paul YamauchiSanta Monica$7.8M
- Navid EzraThousand Oaks$7.8M
- Paul WallaceBeverly Hills$7.1M
- April ArmstrongLos Angeles$6.2M
- David RayhanHuntington Beach$5.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.